Heart-failure transition safety
Entresto transitions: count the 36-hour ACE-inhibitor washout
A new prescription does not prove an old ACE inhibitor has been stopped long enough. Entresto requires a 36-hour separation when switching from or to an ACE inhibitor, and its valsartan component changes the reconciliation check.
Sources checked October 13, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Anchor the interval to the last actual dose
The label contraindicates concomitant ACE-inhibitor use and says not to administer within 36 hours of switching from or to an ACE inhibitor. The interval starts from the last dose, not the time the new prescription was entered or the date the old medicine disappeared from the list.
Medication reconciliation should recover what the patient actually took. An order marked discontinued yesterday is not enough if a dose was taken this morning. Use actual administration history for a clock calculation.
Recognize the two-drug product
Entresto contains sacubitril and valsartan. The interaction section says to avoid another ARB because valsartan is already present. This is not the same mechanism or timing instruction as the ACE-inhibitor washout, but both can appear in one incomplete medication list.
A patient who receives a new combination product may not recognize that an old valsartan tablet duplicates one ingredient. The pharmacist should resolve the list rather than merely attaching a 36-hour note to every renin-angiotensin medicine.
Check contraindications independently of the clock
A history of angioedema related to previous ACE-inhibitor or ARB therapy is a separate contraindication. Waiting 36 hours does not erase that history. Entresto also has fetal-toxicity warnings and requires monitoring of renal function, potassium and blood pressure.
The washout calculation is therefore one gate, not a complete suitability assessment. A case that supplies both a correct interval and a prior angioedema history should not be answered with timing alone.
State a precise transition assessment
For a last lisinopril dose at 08:00 on Monday, 36 hours ends at 20:00 on Tuesday. A planned 08:00 Tuesday dose is only 24 hours later. The difference is twelve hours, not a vague suggestion to wait another day.
Actual treatment timing must be confirmed with the clinical team, especially if the dose history is uncertain or the patient's condition changes. The fictional calculation illustrates the labeled minimum and does not issue a new patient prescription.
A worked case
A patient reports the last lisinopril dose at 08:00 Monday. Entresto is planned for 08:00 Tuesday, with the old valsartan tablet still on the list. What needs correction?
- The proposed interval is 24 hours, not 36.
- The 36-hour point is 20:00 Tuesday using the stated last dose.
- A separate valsartan tablet also needs reconciliation because Entresto contains valsartan.
Answer: The plan starts too soon after the ACE inhibitor and retains a duplicate ARB ingredient. Review both issues before administration.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Is 08:00 Tuesday 36 hours after 08:00 Monday?
No. It is 24 hours.
2. Does Entresto already contain an ARB?
Yes, valsartan.
3. Does waiting 36 hours remove the prior angioedema contraindication?
No.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.